Cdk2 and Cdk4 Regulate the Centrosome Cycle and Are Critical Mediators of Centrosome Amplification in p53-Null Cells

被引:88
作者
Adon, Arsene M. [1 ]
Zeng, Xiangbin [1 ]
Harrison, Mary K. [1 ]
Sannem, Stacy [1 ]
Kiyokawa, Hiroaki [2 ]
Kaldis, Philipp [3 ]
Saavedra, Harold I. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Inst Mol & Cell Biol, Cell Div & Canc Lab PRK, Singapore 138673, Singapore
关键词
GENOMIC INSTABILITY; DEPENDENT KINASE; P21(WAF1/CIP1) DEFICIENCY; CENTRIOLE OVERDUPLICATION; CHROMOSOME INSTABILITY; TARGETED DISRUPTION; DUPLICATION; P53; ANEUPLOIDY; CANCER;
D O I
10.1128/MCB.00253-09
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The two mitotic centrosomes direct spindle bipolarity to maintain euploidy. Centrosome amplification-the acquisition of >= 3 centrosomes-generates multipolar mitoses, aneuploidy, and chromosome instability to promote cancer biogenesis. While much evidence suggests that Cdk2 is the major conductor of the centrosome cycle and that it mediates centrosome amplification induced by various altered tumor suppressors, the role played by Cdk4 in a normal or deregulated centrosome cycle is unknown. Using a gene knockout approach, we report that Cdk2 and Cdk4 are critical to the centrosome cycle, since centrosome separation and duplication are premature in Cdk2(-/-)mouse embryonic fibroblasts (MEFs) and are compromised in Cdk4(-/-) MEFs. Additionally, ablation of Cdk4 or Cdk2 abrogates centrosome amplification and chromosome instability in p53-null MEFs. Absence of Cdk2 or Cdk4 prevents centrosome amplification by abrogating excessive centriole duplication. Furthermore, hyperactive Cdk2 and Cdk4 deregulate the licensing of the centrosome duplication cycle in p53-null cells by hyperphosphorylating nucleophosmin (NPM) at Thr199, as evidenced by observations that ablation of Cdk2, Cdk4, or both Cdk2 and Cdk4 abrogates that excessive phosphorylation. Since a mutant form of NPM lacking the G(1) Cdk phosphorylation site (NPMT199A) prevents centrosome amplification to the same extent as ablation of Cdk2 or Cdk4, we conclude that the Cdk2/Cdk4/NPM pathway is a major guardian of centrosome dysfunction and genomic integrity.
引用
收藏
页码:694 / 710
页数:17
相关论文
共 76 条
[1]
Chromosome aberrations in solid tumors [J].
Albertson, DG ;
Collins, C ;
McCormick, F ;
Gray, JW .
NATURE GENETICS, 2003, 34 (04) :369-376
[2]
Cdc2-cyclin E complexes regulate the G1/S phase transition [J].
Aleem, E ;
Kiyokawa, H ;
Kaldis, P .
NATURE CELL BIOLOGY, 2005, 7 (08) :831-U93
[3]
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21(WAF1) [J].
Ball, KL ;
Lain, S ;
Fahraeus, R ;
Smythe, C ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (01) :71-80
[4]
Bearss DJ, 2002, CANCER RES, V62, P2077
[5]
Cdk2 knockout mice are viable [J].
Berthet, C ;
Aleem, E ;
Coppola, V ;
Tessarollo, L ;
Kaldis, P .
CURRENT BIOLOGY, 2003, 13 (20) :1775-1785
[6]
Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation [J].
Berthet, Cyril ;
Klarmann, Kimberly D. ;
Hilton, Mary Beth ;
Suh, Hyung Chan ;
Keller, Jonathan R. ;
Kiyokawa, Hiroaki ;
Kaldis, Philipp .
DEVELOPMENTAL CELL, 2006, 10 (05) :563-573
[7]
Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis [J].
Castedo, Maria ;
Coquelle, Arnaud ;
Vitale, Ilio ;
Vivet, Sonia ;
Mouhamad, Shahul ;
Viaud, Sophie ;
Zitvogel, Laurence ;
Kroemer, Guido .
SIGNAL TRANSDUCTION PATHWAYS, PT A: APOPTOTIC AND EXTRACELLULAR SIGNALING, 2006, 1090 :35-49
[8]
Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies [J].
Cha, H ;
Hancock, C ;
Dangi, S ;
Maiguel, D ;
Carrier, F ;
Shapiro, P .
BIOCHEMICAL JOURNAL, 2004, 378 :857-865
[9]
CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells [J].
Chen, ZH ;
Indjeian, VB ;
McManus, M ;
Wang, LY ;
Dynlacht, BD .
DEVELOPMENTAL CELL, 2002, 3 (03) :339-350
[10]
Coleman WB, 1999, ANTICANCER RES, V19, P4645